Table 1.
ETC substrates and inhibitors used to isolate specific complexes
Complex | Substrates/inhibitors | Complex‐specific inhibitor |
---|---|---|
I | Pyruvate (10 mM)/malate (1 mM) | Rotenone (2 µM) |
II | Succinate (10 mM)/rotenone (2 µM) | Antimycin A (2 µM) |
III | Succinate (10 mM)/rotenone (2 µM) | Malonate (20 mM) |
IV | Ascorbate (10 mM)/TMPD (100 µM) | Azide (20 µM) |
V | Succinate (10 mM) | Oligomycin (2.5 µg/ml) |